Clinical Study
A Dual 5α-Reductase Inhibitor Dutasteride Caused Reductions in Vascular Density and Area in Benign Prostatic Hyperplasia
Table 1
Characteristics of Patients and TUR-P.
| | Control group | Dutasteride group | value |
| Number |
12
|
15
| | Age (years) | | |
0.1294
| Height (cm) | | |
0.9609
| Body weight (kg) | | |
0.7508
| Body mass index | | |
0.4792
| Prostate volume at first visit (cm3) | | |
0.1021
| Duration of dutasteride administration (weeks) | — | | | Reduction in prostate volume (%) | — | | | Operation time (min) | | |
0.9027
| Operative intravenous crystalloid infusion (mL) | | |
0.1011
| Weight of resected prostate tissue (g) | | |
0.3528
| Hb (g/dL) | | | | Before TUR-P | | |
0.6080
| After TUR-P | | |
0.7320
| Changes in Hb (g/dl) | | |
0.3167
| Hct (%) | | | | Before TUR-P | | |
0.9222
| After TUR-P | | |
0.6429
| Changes in Hct (%) | | |
0.9611
| Na (nmol/L) | | | | Before TUR-P | | |
0.9603
| After TUR-P | | |
0.7125
| Changes in Na (nmol/L) | | |
0.3894
|
|
|
Hb: blood hemoglobin, Hct: hematocrit, and Na: serum sodium. Values are exBeforessed as the mean ± SD. values are from the Mann-Whitney test.
|